REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Shanghai Bao Pharmaceuticals Co. Ltd. (上海宝济药业股份有限公司) (China)

Main Activities: Biological Product (except Diagnostic) Manufacturing
Secondary Activities: Pharmaceutical Preparation Manufacturing
Full name: Shanghai Bao Pharmaceuticals Co. Ltd. Profile Updated: March 17, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Shanghai Bao Pharmaceuticals Co. Ltd. (上海宝济药业股份有限公司) is an enterprise based in China. Its main office is in Hong Kong. It operates in the Biological Product (except Diagnostic) Manufacturing industry. The enterprise was incorporated on April 03, 2026. From the latest financial highlights, Shanghai Bao Pharmaceuticals Co. Ltd. (上海宝济药业股份有限公司) reported a net sales revenue increase of 2716.23% in Q2C2025. The net profit margin of Shanghai Bao Pharmaceuticals Co. Ltd. (上海宝济药业股份有限公司) increased by 10783.87% in 2025.

Headquarters
Room 1919, 19/F, Lee Garden One, 33 Hysan Avenue
Hong Kong; Hong Kong;

Contact Details: Purchase the Shanghai Bao Pharmaceuticals Co. Ltd. (上海宝济药业股份有限公司) report to view the information.

Website: http://www.baopharma.com

Basic Information
Outstanding Shares:
Purchase the Shanghai Bao Pharmaceuticals Co. Ltd. (上海宝济药业股份有限公司) report to view the information.
Financial Auditors:
Purchase the Shanghai Bao Pharmaceuticals Co. Ltd. (上海宝济药业股份有限公司) report to view the information.
Incorporation Date:
April 03, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
32.03%
Purchase this report to view the information.
18.6%
Purchase this report to view the information.
11.8%
Purchase this report to view the information.
7.65%
Purchase this report to view the information.
4.37%
Subsidiaries
Suzhou Centergene Pharmaceuticals Co., Ltd.
66.18%
Company Performance
Financial values in the chart are available after Shanghai Bao Pharmaceuticals Co. Ltd. (上海宝济药业股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
2716.23%▲
Total Operating Revenue
2296.1%▲
Operating Profit
-9.82%▼
EBITDA
-10%▼
Net Profit/Loss for the Period
-9.45%▼
Operating Profit Margin
10800.65%▲
Net Profit Margin
10783.87%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo